Antibiotic prevention of acute exacerbations of COPD

dc.contributor.authorGarcia Vidal, Carolina
dc.contributor.authorViasus, Diego
dc.contributor.authorCarratalà, Jordi
dc.date.accessioned2020-04-24T10:04:33Z
dc.date.available2020-04-24T10:04:33Z
dc.date.issued2012-07-26
dc.date.updated2020-04-24T10:04:33Z
dc.description.abstractTo the Editor: Wenzel and colleagues (July 26 issue) recommend long-term azithromycin for a 55-year-old man with recurrent exacerbations of chronic obstructive pulmonary disease (COPD), a forced expiratory volume in 1 second (FEV1) of 50% of the predicted value, dyspnea, cough, and sputum production. However, before azithromycin, we think this patient should be treated with other pharmacologic agents to manage his COPD and prevent exacerbations.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec617510
dc.identifier.issn0028-4793
dc.identifier.pmid22830464
dc.identifier.urihttps://hdl.handle.net/2445/157357
dc.language.isoeng
dc.publisherMassachusetts Medical Society
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1056/NEJMct1115170
dc.relation.ispartofNew England Journal of Medicine, 2012, vol. 367, num. 4, p. 340-347
dc.relation.urihttps://doi.org/10.1056/NEJMct1115170
dc.rights(c) Massachusetts Medical Society, 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationAntígens bacterians
dc.subject.classificationÚs terapèutic
dc.subject.classificationMalalties del pulmó
dc.subject.otherBacterial antigens
dc.subject.otherTherapeutic use
dc.subject.otherPulmonary diseases
dc.titleAntibiotic prevention of acute exacerbations of COPD
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
617510.pdf
Mida:
332.92 KB
Format:
Adobe Portable Document Format